Trial Profile
A non-randomised cohort study to evaluate immunogenicity and reactogenicity of adult formulation diphtheria-tetanus-pertussis vaccine in healthy adult healthcare workers and researchers working with children: a comparison of those who have previously received a booster and those who are previously unvaccinated
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Therapeutic Use
- 12 Jun 2018 Status changed from active, no longer recruiting to completed.
- 21 Jun 2017 Planned End Date changed from 1 Dec 2016 to 22 Feb 2018.
- 21 Jun 2017 Status changed from not yet recruiting to active, no longer recruiting.